Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304)-Reference-Cited by-同舟云学术

Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304)

Published:2014-07-15 Issue:21 Volume:120 Page:3329-3337
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ulrich Cornelia M.¹²³,Rankin Cathryn⁴,Toriola Adetunji T.⁵,Makar Karen W.³,Altug-Teber Özge¹²,Benedetti Jacqueline K.⁴,Holmes Rebecca S.⁶,Smalley Stephen R.⁷,Blanke Charles D.⁶,Lenz Heinz-Josef⁸

Affiliation:

1. Division of Preventive Oncology; National Center for Tumor Diseases; Heidelberg Germany

2. German Cancer Research Center and German Consortium for Translational Cancer Research; Heidelberg Germany

3. Public Health Sciences Division; Fred Hutchinson Cancer Research Center; Seattle Washington

4. Southwest Oncology Group Statistical Center; Seattle Washington

5. Department of Surgery, Division of Public Health Sciences and Siteman Cancer Center; Washington University School of Medicine; St. Louis Missouri

6. Knight Cancer Institute, Oregon Health and Science University; Portland Oregon

7. Radiation Oncology Center, Olathe Regional Oncology Center; Olathe Kansas

8. Division of Medical Oncology, Keck School of Medicine, University of Southern California; Los Angeles California

Funder

National Cancer Institute

German Cancer Research Center (DKFZ)

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28830/fullpdf

Reference44 articles.

1. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144;Smalley;J Clin Oncol.,2006

2. Preoperative versus postoperative chemoradiotherapy for rectal cancer;Sauer;N Engl J Med.,2004

3. 5-fluorouracil pharmacogenomics: still rocking after all these years?;Scartozzi;Pharmacogenomics.,2011

4. 5-fluorouracil: mechanisms of action and clinical strategies;Longley;Nat Rev Cancer.,2003

5. Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism;Fredriksen;Hum Mutat.,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy;Frontiers in Genetics;2024-01-15

2. Methylenetetrahydrofolate reductase polymorphic variants in rectal cancer: significance for cancer risk and response to chemoradiotherapy;2023-09-23

3. Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy;Frontiers in Pharmacology;2020-06-17

4. Methylenetetrahydrofolate reductase polymorphisms and colorectal cancer prognosis: A meta‐analysis;The Journal of Gene Medicine;2019-08-06

5. Therapeutic drug monitoring as a tool to optimize 5-FU–based chemotherapy in gastrointestinal cancer patients older than 75 years;European Journal of Cancer;2019-04